US Stocks
/
Cognition Therapeutics, Inc. Share Price

Cognition Therapeutics, Inc. Share Price

NASDAQ: CGTX | Micro Cap
$0.88
-$0.02 (-2.16%) Last updated on 10 Oct, 2026 | 01:23 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cognition Therapeutics, Inc. Stock Performance

Open
$0.90
Prev. Close
$0.89
Circuit Range
N/A
Day Range
$0.88 - $0.90
Year Range
$0.55 - $2.02
Volume
2,929
Average Traded
$0.88

Cognition Therapeutics, Inc. Share Price Today

As of 10 October 2026, Cognition Therapeutics, Inc.'s share price is $0.88. The stock opened at $0.90, compared to its previous close of $0.89. During today's trading session, Cognition Therapeutics, Inc.'s share price traded between $0.88 and $0.90, with an average price of $0.89. Over the past 52 weeks, the stock has recorded a high of $2.02 and a low of $0.55. In terms of performance, Cognition Therapeutics, Inc.'s share price has declined by 30.83% over the last six months and is down 51.25% on a year-on-year basis.

Cognition Therapeutics, Inc. Share Price Chart

$0.88$0.90
L
Show Current Price
H

Cognition Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$63.67M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.18
Revenue (TTM)
$0.00
Return On Equity (TTM)
-50.80%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
20.28%

Cognition Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$4.93-$3.34-$4.57-$3.93
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A32.25%-36.83%14.00%

Cognition Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$21.40-$25.79-$33.97-$23.49
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-20.51%-31.72%30.85%

About Cognition Therapeutics, Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina. It aims to develop disease-modifying therapies for patients with these disorders. Its product candidate, zervimesine (CT1812), is an orally delivered small molecule designed to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, including beta-amyloid and alpha-synuclein. These protein oligomers have been linked to the progression of degenerative diseases such as Alzheimer's disease (AD) and dementia with Lewy bodies (DLB).

Cognition Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$0.94
$0.88
-8.85%
Sep 2026
$1.02
$0.96
-11.11%
Aug 2026
$0.90
$1.08
+21.21%
Jul 2026
$1.19
$0.89
-22.52%
Jun 2026
$1.17
$1.15
-3.36%
May 2026
$1.26
$1.19
-5.93%
Apr 2026
$0.83
$1.26
+67.11%
Mar 2026
$1.07
$0.76
-30.23%
Feb 2026
$1.13
$1.08
+0.46%
Jan 2026
$1.40
$1.08
-19.40%
Dec 2025
$1.74
$1.34
-22.32%
Nov 2025
$1.76
$1.73
-3.90%

CGTX Share Price FAQs

What is Cognition Therapeutics, Inc. share price today?

chevron-up
Cognition Therapeutics, Inc. share price today is $0.88 as on October 10, 2026 at 1:23 am IST.

What is the 52 week high and 52 week low of Cognition Therapeutics, Inc. stock?

chevron-up
The 52 week high of Cognition Therapeutics, Inc. stock is $2.02, while the 52 week low is $0.55 as of 10 Oct '26.

What is CGTX's market capitalisation today?

chevron-up
CGTX market capitalisation is $63.67M as of October 10, 2026, at 4:43 am IST.

What is CGTX's net income for the last quarter?

chevron-up
CGTX's net income for the last quarter is -3.93B USD.

What is the 5 year returns of CGTX?

chevron-up
The 5 year returns of CGTX is -92.76% as on 10 Oct '26.

What is the high & low stock price of CGTX today?

chevron-up
CGTX stock price hit a high of $0.90 and low of $0.88 as of 10 Oct '26.

Can I buy CGTX shares in India?

chevron-up
Yes. You can buy CGTX in India by opening an international trading account.